The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today ...

Fifteen years after Basilea's antibiotic ceftobiprole sustained a rejection from the FDA, the company has finally won over the U.S. regulator and done so in triplicate. The FDA has approved Basilea’s ...

Innoviva (INVA) announced it has entered into an exclusive distribution and license agreement with Basilea Pharmaceutica for the commercialization of Zevtera, an advanced-generation cephalosporin ...

Zevtera is supplied as a single-dose vial containing 667 mg of ceftobiprole medocaril sodium as a lyophilized powder for reconstitution. Zevtera ® (ceftobiprole medocaril sodium for injection) is now ...

fully participate in the economic upside of our products. The agreement with Quintiles allows us to scale and optimize our resources during the launch of Zevtera/Mabelio on a country-by-country basis.

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today ...

LONDON (MarketWatch) -- Shares of Basilea Pharmaceutica skidded Tuesday after the Swiss drugmaker saw approval for a skin-infection drug delayed, leading the company to file an arbitration claim ...

LONDON (MarketWatch) -- Shares of Basilea Pharmaceutica plunged 23% in early Swiss trade after saying the EU Committee for Medicinal Products for Human Use has delayed its decision on whether to ...

ZEVTERA is the first and only U.S. Food and Drug Administration-approved cephalosporin indicated to treat Staphylococcus aureus bacteremia (SAB), including right-sided endocarditis, caused by the ...